Pipeline — registered trials by phase
Lifestyle Intervention Program for Former Elite Athletes
— · Obesity · Completed · est. 2020-10
Individualization of Ovarian Stimulation Using AMH Maximizes the Benefits and Minimizes Complications and Risks
— · Infertility · Completed · est. 2013-06
Psychomotor Therapy Effects in Adaptive Behavior and Motor Proficiency in Intellectual Disability
— · Intellectual Disability · Completed · est. 2015-07
The Motor Neurological Soft Signs (MNSS) in Persons With Schizophrenia
— · Psychomotor Status, Schizophrenia, Motor Skills Disorders · Completed · est. 2019-12
Effects of the Menstrual Cycle and Oral Contraceptive Use on Health and Performance in Athletes
— · Menstrual Cycle, Oral Contraceptive Use, Athlete · Recruiting · est. 2027-12-01
The Effects of High Intensity Circuit Training in Nature Vs. Indoor on Exercise Performance, and Wellbeing
— · Green Exercise, Indoor Exercise · Completed · est. 2023-11-30
Effect of Galactooligosaccharides on Incidence of Atopic Manifestations in Infants
— · Atopic Dermatitis · Completed · est. 2012-11
More Health Less Diabetes
— · Pre-diabetes · Recruiting · est. 2026-07-30
The Effects of Leucine Metabolites in Performance, Body Composition and Biochemical Markers of Muscle Damage
— · Resistance Training · Completed · est. 2017-10-28
Effects of Heart Rate Variability-guided Training vs Standard Aerobic Prescription on Cardiovagal Modulation and Cardiorespiratory Fitness in Coronary Artery Disease
— · Coronary Arterial Disease (CAD) · Not Yet Recruiting · est. 2027-12-01
Effect of Sodium Bicarbonate on Exercise Performance
— · Sodium Bicarbonate · Completed · est. 2022-04-27
Breaking of Sitting Time Prevents Lower Leg Swelling
— · Edema Leg · Completed · est. 2020-06-30
Lifestyle Intervention in Overweight Women
— · Obesity, Weight Loss, Lifestyle, Sedentary · Completed · est. 2003-07-01
Effects of Facemask on Cardiorespiratory Performance
— · Facemask Impact on Cardiorespiratory Performance · Completed · est. 2021-01-30
Combined Exercise Effects in Breast Cancer-related Lymphedema
— · Breast Cancer-Related Lymphedema · Not Yet Recruiting · est. 2027-12
Hypoalgesic Effects of Exercise and Training of Different Modalities
— · Training, Exercise, Fatigue · Completed · est. 2022-12-30
Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin Therapy
— · Non-obstructive Azoospermia, Hormone Deficiency, Hypogonadism, Male · Completed · est. 2021-09-15
"Living Low - Training High" Methods and Physiological Responses in Well-trained Swimmers
— · Normobaric Hypoxia, Hypoventilation, Normoxia · Completed · est. 2025-04-15
Effects of a Resistance and Stretching Training Program on Forward Head and Protracted Shoulder Posture Adolescents
— · Posture Disorders in Children · Completed · est. 2013-05
Low-dose GH Supplementation Increases Clinical Pregnancy Rate
— · Infertility · Completed · est. 2016-12
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Humana is lead sponsor; 20 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-10-09Current report (material event)
- 8-K2026-09-01Current report (material event)
- 10-Q2026-07-29Quarterly report
- 8-K2026-07-29Current report (material event)
- 8-K2026-07-29Current report (material event)
- 11-K2026-06-2411-K
- 11-K2026-06-2411-K
- 8-K2026-06-01Current report (material event)
- 8-K2026-05-19Current report (material event)
- SCHEDULE 13G/A2026-05-14SCHEDULE 13G/A
- SCHEDULE 13G2026-04-30SCHEDULE 13G
- 10-Q2026-04-29Quarterly report
- 8-K2026-04-29Current report (material event)
- 8-K2026-04-20Current report (material event)
- S-82026-04-16Employee stock plan
- 8-K2026-04-10Current report (material event)
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 8-K2026-03-09Current report (material event)
- DEFR14A2026-03-06DEFR14A
- 424B52026-03-06Prospectus (offering)
- ARS2026-03-06Annual report to holders
- DEFA14A2026-03-06DEFA14A
- DEF 14A2026-03-06Proxy statement
- FWP2026-03-05FWP
- 424B52026-03-05Prospectus (offering)
- POSASR2026-03-05POSASR
- 8-K2026-03-02Current report (material event)
- 10-K2026-02-19Annual report
- 8-K2026-02-11Current report (material event)
- S-8 POS2025-12-19S-8 POS
- 8-K2025-12-16Current report (material event)
- 8-K2025-12-01Current report (material event)
- 10-Q2025-11-05Quarterly report
- 8-K2025-11-05Current report (material event)
- 8-K2025-10-02Current report (material event)
- 8-K2025-08-29Current report (material event)
- 10-Q2025-07-30Quarterly report
- 8-K2025-07-30Current report (material event)
- SCHEDULE 13G/A2025-07-29SCHEDULE 13G/A
- 11-K2025-06-1711-K
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.